Knockdown of STAT3 by iRNA Inhibiting Migration and Invasion of Epithelial Ovarian Cancer Cells

被引:0
作者
Li Qin-hua [1 ]
Zhu Ji-hong [1 ]
Liu Lei [2 ]
Yue Ying [1 ]
机构
[1] Jilin Univ, Hosp 1, Dept Gynecol, Changchun 130021, Peoples R China
[2] Jilin Univ, Hosp 1, Dept Gastroenterol, Changchun 130021, Peoples R China
关键词
Ovarian cancel model SK-OV-3 cell; Signal transducer and activator of transcription 3(STAT3); Migration; Vascular endothelial growth factor(VEGF); Survivin; ENDOTHELIAL GROWTH-FACTOR; UP-REGULATION; SURVIVIN; VEGF; EXPRESSION; APOPTOSIS; METASTASIS; THERAPY; PATHWAY; MICROENVIRONMENT;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Signal transducer and activator of transcription 3(STAT3) is a dual functional transcription factor with the functions of signal transduction and transcription regulation. It is reported that the expression of STAT3 in ovarian cancer is significantly higher and STAT3 can facilitate ovarian cancer growth and metastasis. To clarify the definite effect and molecular mechanism of STAT3 involved in ovarian cancer growth and metastasis, STAT3 expression was significantly downregulated by transfecting ovarian cancer model SK-OV-3 cells with the plasmid vector which express specific RNAi that targets human STAT3. The downregulated STAT3 not only decreased the invasion and migration but also inhibited the proliferation of SK-OV-3 cells. Western blot assay shows that the expression of vascular endothelial growth factor(VEGF) and that of Survivin were reduced in the cells with the plasma vector expressing specific RNAi that targets human STAT3. These results demonstrate that STAT3 involved in the invasion and migration of SK-OV-3 regulates the expression of VEGF and Survivin. In addition, VEGF and Survivin could play an important role in ovarian cancer growth and metastasis.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 35 条
[1]   New wirings in the survivin networks [J].
Altieri, D. C. .
ONCOGENE, 2008, 27 (48) :6276-6284
[2]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[3]   Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten [J].
Barbieri, Isaia ;
Pensa, Sara ;
Pannellini, Tania ;
Quaglino, Elena ;
Maritano, Diego ;
Demaria, Marco ;
Voster, Alessandra ;
Turkson, James ;
Cavallo, Federica ;
Watson, Christine J. ;
Provero, Paolo ;
Musiani, Piero ;
Poli, Valeria .
CANCER RESEARCH, 2010, 70 (06) :2558-2567
[4]   Expression of Angiogenic Regulators, VEGF and Leptin, Is Regulated by the EGF/PI3K/STAT3 Pathway in Colorectal Cancer Cells [J].
Cascio, Sandra ;
Ferla, Rita ;
D'Andrea, Aleco ;
Gerbino, Aldo ;
Bazan, Viviana ;
Surmacz, Eva ;
Russo, Antonio .
JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 221 (01) :189-194
[5]   A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy [J].
Cheung, Chun Hei Antonio ;
Sun, Xueying ;
Kanwar, Jagat R. ;
Bai, Ji-Zhong ;
Cheng, LiTing ;
Krissansen, Geoffrey W. .
CANCER CELL INTERNATIONAL, 2010, 10
[6]   Small molecule inhibitors of Stat3 signaling pathway [J].
Deng, Jinxia ;
Grande, Fedora ;
Neamati, Nouri .
CURRENT CANCER DRUG TARGETS, 2007, 7 (01) :91-107
[7]   Tumor Microenvironment and Progression [J].
Dvorak, Harold F. ;
Weaver, Valerie M. ;
Tlsty, Thea D. ;
Bergers, Gabriele .
JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (06) :468-474
[8]   Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters [J].
Ferrandina, G ;
Legge, F ;
Martinelli, E ;
Ranelletti, FO ;
Zannoni, GF ;
Lauriola, L ;
Gessi, M ;
Gallotta, V ;
Scambia, G .
BRITISH JOURNAL OF CANCER, 2005, 92 (02) :271-277
[9]   Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy [J].
Germain, Doris ;
Frank, David A. .
CLINICAL CANCER RESEARCH, 2007, 13 (19) :5665-5669
[10]   Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells [J].
Gritsko, T ;
Williams, A ;
Turkson, J ;
Kaneko, S ;
Bowman, T ;
Huang, M ;
Nam, S ;
Eweis, I ;
Diaz, N ;
Sullivan, D ;
Yoder, S ;
Enkemann, S ;
Eschrich, S ;
Lee, JH ;
Beam, CA ;
Cheng, J ;
Minton, S ;
Muro-Cacho, CA ;
Jove, R .
CLINICAL CANCER RESEARCH, 2006, 12 (01) :11-19